ʻIke Kumu | |
Inoa mea kūʻai | 112811-59-3 |
Papa | Papa Laau Laau |
Ka nana aku | Keʻokeʻo a i ʻole ka pauka kristal keʻokeʻo |
Hoʻāʻo | 99% |
Ola ola | 2 makahiki |
Hoʻopili | 25kg / pahu |
Waihona | E mālama i kahi maloʻo maloʻo |
wehewehe huahana
Aia ʻo Gatifloxacin i ka papa o nā lāʻau i kapa ʻia ʻo quinolone antibiotics a hoʻohana ʻia e mālama i nā maʻi sinus acute, māmā, a i ʻole nā maʻi ʻano mimi a me nā maʻi bacteria i hoʻouna ʻia ma ke kāne. Me ka gatifloxacin e komo pū me ka nausea, ka vaginitis (ka ʻeha a i ʻole ka ʻā ʻana o ka ʻōpū), ka maʻi ʻeha, ke poʻo ʻeha, ka ʻūhā, a me nā kuʻi puʻuwai ʻole.Ma keʻano laulā, hoʻohana ʻia ka gatifloxacin i nā poʻe i pane ʻole i nā lāʻau AOM ʻē aʻe.
Ma hoʻokahi haʻawina, ua hoʻohālikelike ʻia ka gatifloxacin me ka amoxicillin / clavulanate i ka mālama ʻana i ka otitis media (OM) a me ka AOM i nā hemahema o ka mālama ʻana i nā keiki. Ua hōʻike ʻia nā hopena ua ʻae maikaʻi ʻia nā lāʻau ʻelua;ʻO ka hopena maʻamau ka maʻi maʻi. Ua hoʻoholo nā mea noiʻi ʻo ka mālama ʻana me ka gatifloxacin hoʻokahi manawa i kēlā me kēia lā e like me ka amoxicillin / clavulanate ʻelua i kēlā me kēia lā.
Laau Laau Laau
Aia ka spectrum me Acinetobacter spp a me Aeromonas spp, akā ʻaʻole ikaika loa ia iā Ps.aeruginosa a me nā lāʻau Gram-negative non-fermentative.ʻOi aku ka ikaika e kūʻē i nā maʻi methicillin-susceptible o staphylococci ma mua o nā lāʻau pale methicillin.Hoʻoikaika pū ia i ka Chlamydia, Mycoplasma a me Legionella spp.a loaʻa iā ia kekahi hana kūʻē i nā anaerobes.
ʻAneʻane hoʻopaʻa ʻia ke hāʻawi waha ʻia a hoʻolaha nui ʻia i loko o ke kino i loko o nā ʻiʻo kino a me nā wai.ʻO ka hapalua ola o ka plasma he 6-8 mau hola.ʻOi aku ma mua o 70% o ka lāʻau lapaʻau i hoʻololi ʻole ʻia i ka mimi.Hoʻemi ʻia ka hoʻomaʻemaʻe renal e 57% i ka lawa ʻole o ka renal a me ka 77% i ka lawa ʻole o ka renal.
ʻO ka hoʻolōʻihi ʻana o ka manawa QTC i kekahi mau maʻi a me ka hoʻopilikia ʻana i ka maʻi diabetes mellitus i hopena i ka haʻalele ʻana o ka lāʻau lapaʻau ma ka hapa nui o nā ʻāina no ka hoʻohana ʻana i ka ʻōnaehana.Hoʻohana mau ʻia ʻo Gatifloxacin ma ʻAmelika ʻĀkau ma ke ʻano he ophthalmic solution.
Nā hopena ʻaoʻao
Hoʻopili maikaʻi ʻia ʻo Gatifloxacin mai ka gastrointestinal tract (loaʻa waha ma kahi o 100%), a me ka hoʻokele concomitant o ka ʻaina kakahiaka continental, 1050 kcal, ʻaʻohe hopena i kona loaʻa.ʻO ka maʻamau maʻamau ʻo 400 mg od a loaʻa nā ʻōlelo waha a me ka intravenous formulations.
Nā hopena maʻamau
Ka ino o ka ma'i maka
ʻO ka huhū maka
ʻEha maka
Hoʻololi i ka ʻono